The growth of the global biosimilar monoclonal antibody market is driven by increase in prevalence of chronic diseases globally, increase in the number of product approvals and increase in the number of patent expirations. PORTLAND, Ore., Sept. 18, 2023 /PRNewswire/ — Allied Market…